Gregory Z. Ferl - Concepedia

Author

Gregory Z. Ferl

University of California, Los Angeles ORCID

Also Known As

G Z Ferl, G. Z. Ferl, Gregory Z. Ferl

Publications

924

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Gene Therapy Laboratory Howard Hughes Medical Institute University of Freiburg Sunesis (United States)

About

Gregory Z. Ferl is an author at University of California, Los Angeles specializing in medicine, health sciences, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	353
2	Health Sciences	3	3	148
3	Cell Biology	3	3	249
4	Engineering	1	1	11
5	Biostatistics	1	1	11

Gregory Z. Ferl

Publications

809

Citations

H-Index

Page 1

	Year	Citations
A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn) Gregory Z. Ferl, Anna M. Wu, Joseph J. DiStefano Annals of Biomedical Engineering Predictive ModelSystems BiologySignal TransductionImmunocytochemical TechniqueImmunology	2005	141
Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors Helen C. Su, Yann Seimbille, Gregory Z. Ferl, European Journal of Nuclear Medicine and Molecular Imaging Molecular Imaging ProbeOncologic ImagingMedicinePathologyTherapeutic Imaging	2008	104
Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes Gregory Z. Ferl, Sam S. An, Amber C. Donahue, Proceedings of the National Academy of Sciences Phosphoinositide 3-KinaseSignal TransductionSignaling PathwayCell DivisionCell Regulation	2001	75
Estimation of the 18F-FDG Input Function in Mice by Use of Dynamic Small-Animal PET and Minimal Blood Sample Data Gregory Z. Ferl, Xiaoli Zhang, Hui‐Yuan Wu, Journal of Nuclear Medicine	2007	70
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments Gregory Z. Ferl, Vania Kenanova, Anna M. Wu, Molecular Cancer Therapeutics	2006	62
Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow C. Andrew Boswell, Gregory Z. Ferl, Eduardo E. Mundo, PLoS ONE	2011	36
A Preclinical Population Pharmacokinetic Model for Anti‐CD20/CD3 T‐Cell‐Dependent Bispecific Antibodies Gregory Z. Ferl, Arthur E. Reyes, Liping Sun, Clinical and Translational Science	2018	35
An automated method for nonparametric kinetic analysis of clinical DCE‐MRI data: Application to glioblastoma treated with bevacizumab Gregory Z. Ferl, Lu Xu, Michel Friesenhahn, Magnetic Resonance in Medicine	2010	34
Derivation of a Compartmental Model for Quantifying <sup>64</sup>Cu-DOTA-RGD Kinetics in Tumor-Bearing Mice Gregory Z. Ferl, Rebecca A. Dumont, Isabel J. Hildebrandt, Journal of Nuclear Medicine	2009	33
VCAM-1 Density and Tumor Perfusion Predict T-cell Infiltration and Treatment Response in Preclinical Models Johannes Riegler, Herman Gill, Annie Ogasawara, Neoplasia Cell TherapyOncologic ImagingT-regulatory CellImmunologyImmunoediting	2019	33

Page 1